Alcino Silva (born September 30, 1990) is a sprint canoer from So Tom and Prncipe who competed in the late 2000s. At the 2008 Summer Olympics in Beijing, ...
Us Patents
Treating Learning Deficits With Inhibitors Of Hmg Coa Reductase
The disclosure provides methods of treating cognitive disorders by administering a HMG CoA reductase inhibitor. Cognitive deficits treatable with the inhibitor compound include those associated with Angelman Syndrome, Neurofibromatosis-1, certain forms of X-linked mental retardation, tuberous sclerosis, Down Syndrome, autism, and attention deficit/hyperactivity disorder.
Treating Learning Deficits With Inhibitors Of Hmg Coa Reductase
Alcino Silva - Sherman Oaks CA, US Yijun Cui - Los Angeles CA, US Weidong Li - Shanghai, CN Steven A. Kushner - Rotterdam, NL
International Classification:
A61K 31/366 A61P 25/00
US Classification:
514460
Abstract:
The disclosure provides methods of treating cognitive disorders by administering a HMG CoA reductase inhibitor. Cognitive deficits treatable with the inhibitor compound include those associated with Angelman Syndrome, Neurofibromatosis-1, certain forms of X-linked mental retardation, tuberous sclerosis, Down Syndrome, autism, and attention deficit/hyperactivity disorder.
Youtube
Alcino Silva | Allen Distinguished Seminar Se...
Alcino Silva presents on: "Molecular, cellular, and circuit mechanisms...
Duration:
1h 11m 2s
Dr Alcino Silva - Can we repair the human bra...
ICT for Life Sciences Forum Presentation, 6 February 2013.
Duration:
54m 25s
ALCINO SILVA- JESUS A VIDA- LBUM COMPLETO. (...
Aqui, esto os ttulos das msicas desse trabalho. 01-PELAS MADRUGADAS. 0...
"Noonan syndrome interferes with the changes in brain cells needed for learning, which results in learning deficits," said Alcino Silva, a professor of neuroscience at the David Geffen School of Medicine at UCLA and senior author on the paper. Lovastatin acts "on the root of the problem and r
Date: Nov 10, 2014
Category: Health
Source: Google
Statins Could Reverse Learning Deficits Associated With Noonan Syndrome
We are excited about these findings, because they suggest that the treatment we developed may help the millions of Noonan patients with intellectual disabilities," said principal investigator Alcino Silva, professor of neurobiology, psychiatry and psychology at the David Geffen School of Medicine a